Agios Pharmaceuticals AGIO Contract Assets
Contract Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNetCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's contract assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's contract assets?
- Agios Pharmaceuticals (AGIO) reported contract assets of $16.13M in Q1 2026.
- How has Agios Pharmaceuticals's contract assets changed year-over-year?
- Agios Pharmaceuticals's contract assets increased by 382.4% year-over-year, from $3.34M to $16.13M.
- What is the long-term trend for Agios Pharmaceuticals's contract assets?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's contract assets has grown at a -13.1% compound annual growth rate (CAGR), from $21.33M to $10.58M.
- What does contract assets mean?
- Revenue recognized under ASC 606 where the right to payment is conditional on something other than the passage of time — work performed but not yet billable.